FDA panel debates “three-parent IVF” genetic modification


Posted on February 28th, by Michael Shapiro-Barr

On Tuesday, February 25, 2014, a FDA panel began debating a new genetic modification technique that involves taking DNA from three individuals and combining them to create embryos free of some inherited diseases.  Scientists think this technique has the potential to be very helpful for women who carry DNA mutations for conditions such as blindness and epilepsy.  The genetic modification would allow women who carry these DNA mutations to have children, without passing on those defects.  While many scientists feel strongly that this technology has huge potential to help people, many critics say the technology could lead to creating “designer” babies.

Read More





Comments are closed.



From the Blog

President Issues Sanctions to Support Stability in Ukraine

Today, March 6, 2014, President Obama signed a new Executive Order in response to the threats Ukraine is facing to its peace and stability....

New Reprint Guidance Maintains Bipartisan Status Quo

On February 28, 2014, the FDA issued its most recent unofficial guidance on distribution by manufacturers of research concerning off-label uses.  With minor textual revisions,...

High Court Should Reverse 4th Circ.’s Flawed FCA Ruling

The U.S. Supreme Court is currently deciding whether to review the Fourth Circuit’s decision in United States ex rel. Carter v. Halliburton Co., 710...